Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Mangoceuticals (MGRX) Short-term Investments (2023 - 2025)

Historic Short-term Investments for Mangoceuticals (MGRX) over the last 3 years, with Q3 2025 value amounting to $16942.0.

  • Mangoceuticals' Short-term Investments changed 0.0% to $16942.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $16942.0, marking a year-over-year change of 0.0%. This contributed to the annual value of $16942.0 for FY2024, which is 0.0% changed from last year.
  • Mangoceuticals' Short-term Investments amounted to $16942.0 in Q3 2025, which was down 0.0% from $16942.0 recorded in Q2 2025.
  • In the past 5 years, Mangoceuticals' Short-term Investments registered a high of $16942.0 during Q4 2023, and its lowest value of $16942.0 during Q4 2023.
  • For the 3-year period, Mangoceuticals' Short-term Investments averaged around $16942.0, with its median value being $16942.0 (2023).
  • Within the past 5 years, the most significant YoY rise in Mangoceuticals' Short-term Investments was 0.0% (2024), while the steepest drop was 0.0% (2024).
  • Over the past 3 years, Mangoceuticals' Short-term Investments (Quarter) stood at $16942.0 in 2023, then changed by 0.0% to $16942.0 in 2024, then changed by 0.0% to $16942.0 in 2025.
  • Its last three reported values are $16942.0 in Q3 2025, $16942.0 for Q2 2025, and $16942.0 during Q1 2025.